Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

61.23USD
3 Jun 2015
Change (% chg)

$0.20 (+0.33%)
Prev Close
$61.03
Open
$61.26
Day's High
$61.73
Day's Low
$60.58
Volume
711,502
Avg. Vol
1,213,514
52-wk High
$75.17
52-wk Low
$38.49

ALKS.O

Chart for ALKS.O

About

Alkermes PLC, is an Ireland-based biopharmaceutical company. The Company is positioned to be an engine of treatments for clinical conditions specifically focused on central nervous system disorders, such as schizophrenia, addiction and depression. The products are based on science and technology that provide treatment options... (more)

Overall

Beta: 1.12
Market Cap(Mil.): $9,070.93
Shares Outstanding(Mil.): 148.63
Dividend: --
Yield (%): --

Financials

  ALKS.O Industry Sector
P/E (TTM): -- 312.37 38.84
EPS (TTM): -0.25 -- --
ROI: -2.05 -5.21 16.53
ROE: -2.64 -6.13 17.62
Search Stocks

CORRECTED-BRIEF-Alkermes says will not pursue further development of ALKS 7106

(Corrects headline to say company will not pursue further development of its drug. The previous headline incorrectly stated that the drug reached main goal) Feb 24 - Alkermes Plc : * Says topline results from a phase 1 clinical study of alks 7106 * Data from the study showed that alks 7106 did not meet the company's pre-specified criteria for advancing into phase 2 clinical trials * Says will not pursue further development of alks 7106 * Will continue its efforts in developing comp

24 Feb 2015

UPDATE 1-Alkermes schizophrenia drug meets main goal in mid-stage trial

(Adds details, stock movement) (Adds details, share move)

07 Jan 2015

Alkermes schizophrenia drug meets main goal in mid-stage trial

Jan 7 - Alkermes Plc said its experimental drug to treat schizophrenia met the main goal in a mid-stage trial.

07 Jan 2015

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks